$101 Million is the total value of JW Asset Management, LLC's 22 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMZN | AMAZON COM INC | $28,407,000 | +23.8% | 19,627 | 0.0% | 28.00% | +14.6% | |
| EGRX | EAGLE PHARMACEUTICALS INC | $25,068,000 | -1.4% | 475,755 | 0.0% | 24.71% | -8.6% | |
| CRON | New | CRONOS GROUP INC | $7,480,000 | – | 1,111,444 | +100.0% | 7.37% | – |
| JNP | JUNIPER PHARMACEUTICALS INC | $4,333,000 | +109.3% | 426,903 | 0.0% | 4.27% | +93.9% | |
| PETQ | Sell | PETIQ INC | $3,960,000 | +7.4% | 148,855 | -11.8% | 3.90% | -0.5% |
| ATRS | Sell | ANTARES PHARMA INC | $3,895,000 | +4.2% | 1,770,524 | -5.7% | 3.84% | -3.5% |
| HZNP | HORIZON PHARMA PLC | $3,845,000 | -2.7% | 270,775 | 0.0% | 3.79% | -9.9% | |
| MSFT | MICROSOFT CORP | $3,788,000 | +6.7% | 41,500 | 0.0% | 3.73% | -1.2% | |
| BSTC | BIOSPECIFICS TECHNOLOGIES CO | $3,266,000 | +2.4% | 73,649 | 0.0% | 3.22% | -5.2% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $3,258,000 | +6.4% | 17,750 | 0.0% | 3.21% | -1.4% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,240,000 | -11.1% | 444,439 | 0.0% | 3.19% | -17.6% | |
| LGND | LIGAND PHARMACEUTICALS INC | $2,213,000 | +20.6% | 13,401 | 0.0% | 2.18% | +11.7% | |
| MU | MICRON TECHNOLOGY INC | $2,138,000 | +26.8% | 41,000 | 0.0% | 2.11% | +17.4% | |
| TSLA | New | TESLA INC | $1,331,000 | – | 5,000 | +100.0% | 1.31% | – |
| CBM | Sell | CAMBREX CORP | $1,230,000 | -49.3% | 23,519 | -53.4% | 1.21% | -53.0% |
| CPIX | Sell | CUMBERLAND PHARMACEUTICALS I | $1,195,000 | -38.5% | 178,942 | -32.2% | 1.18% | -43.0% |
| NVLNF | NOVELION THERAPEUTICS INC | $1,106,000 | +12.2% | 315,979 | 0.0% | 1.09% | +3.9% | |
| ALIM | Sell | ALIMERA SCIENCES INC | $717,000 | -44.2% | 696,000 | -28.0% | 0.71% | -48.3% |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $434,000 | +5.6% | 289,664 | 0.0% | 0.43% | -2.1% | |
| OSTK | OVERSTOCK COM INC DEL | $363,000 | -43.2% | 10,000 | 0.0% | 0.36% | -47.4% | |
| SNOA | SONOMA PHARMACEUTICALS INC | $151,000 | -32.3% | 40,951 | 0.0% | 0.15% | -37.1% | |
| TLGT | TELIGENT INC NEW | $46,000 | -8.0% | 13,820 | 0.0% | 0.04% | -15.1% | |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -178,654 | -100.0% | -0.66% | – |
| FB | Exit | FACEBOOK INCcl a | $0 | – | -37,500 | -100.0% | -7.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.